Concepedia

Lisa A. Hammond

LA

46

Publications

5.3K

Citations

33

H-Index

1999

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

Brooke Army Medical Center

Wilford Hall Ambulatory Surgical Center

Lisa A. Hammond is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1999–2019

46

Publications

46

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

Román Pérez-Soler, Abraham Chachoua, Lisa A. Hammond et al. · Journal of Clinical Oncology · 2004 · 1.1K citations · Full text

Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies

Manuel Hidalgo, Lillian L. Siu, John Nemunaitis et al. · Journal of Clinical Oncology · 2001 · 997 citations

ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial

Malcolm Ranson, Lisa A. Hammond, D. K. Ferry et al. · Journal of Clinical Oncology · 2002 · 762 citations

Cantuzumab Mertansine, a Maytansinoid Immunoconjugate Directed to the CanAg Antigen: A Phase I, Pharmacokinetic, and Biologic Correlative Study

Anthony W. Tolcher, Leonel Ochoa, Lisa A. Hammond et al. · Journal of Clinical Oncology · 2003 · 204 citations

Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies

Lisa A. Hammond, John R. Eckardt, Sharyn D. Baker et al. · Journal of Clinical Oncology · 1999 · 132 citations

Rows per page

1–5 of 46